Molecular subtypes of ductal carcinoma in situ in African American and Caucasian American Women: Distribution and correlation with pathological features and outcome

Perou, 1999, Distinctive gene expression patterns in human mammary epithelial cells and breast cancers, Proc Natl Acad Sci U S A, 96, 9212, 10.1073/pnas.96.16.9212

Sorlie, 2001, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci U S A, 98, 10869, 10.1073/pnas.191367098

Sorlie, 2003, Repeated observation of breast tumor subtypes in independent gene expression data sets, Proc Natl Acad Sci U S A, 100, 8418, 10.1073/pnas.0932692100

Carey, 2006, Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study, JAMA, 295, 2492, 10.1001/jama.295.21.2492

Ihemelandu, 2007, Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome, Ann Surg Oncol, 14, 2994, 10.1245/s10434-007-9477-6

Vastag, 2003, Breast cancer racial gap examined: no easy answers to explain disparities in survival, JAMA, 290, 1838, 10.1001/jama.290.14.1838

Polite, 2005, Breast cancer and race: a rising tide does not lift all boats equally, Perspect Biol Med, 48, S166, 10.1353/pbm.2005.0041

Furberg, 2001, Tumor characteristics in African American and white women, Breast Cancer Res Treat, 68, 33, 10.1023/A:1017994726207

Tamimi, 2008, Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer, Breast Cancer Res, 10, R67, 10.1186/bcr2128

Clark, 2011, Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease, Br J Cancer, 104, 120, 10.1038/sj.bjc.6606021

Nassar, 2009, Ductal carcinoma in situ in African American versus Caucasian American women: analysis of clinicopathologic features and outcome, Cancer, 115, 3181, 10.1002/cncr.24376

Mohsin, 2004, Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study, Mod Pathol, 17, 1545, 10.1038/modpathol.3800229

Adler, 2011, Predictors of disease progression in ductal carcinoma in situ of the breast and vascular patterns, Hum Pathol

Li, 2003, Differences in breast cancer stage, treatment, and survival by race and ethnicity, Arch Intern Med, 163, 49, 10.1001/archinte.163.1.49

Shavers, 2003, Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35, Cancer, 97, 134, 10.1002/cncr.11051

Simon, 2006, Racial differences in breast cancer survival in the Detroit metropolitan area, Breast Cancer Res Treat, 97, 149, 10.1007/s10549-005-9103-x

Lund, 2008, High prevalence of triple-negative tumors in an urban cancer center, Cancer, 113, 608, 10.1002/cncr.23569

Warnberg, 2000, Risk of subsequent invasive breast cancer after breast carcinoma in situ, Lancet, 355, 724, 10.1016/S0140-6736(99)03703-4

Sanders, 2005, The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up, Cancer, 103, 2481, 10.1002/cncr.21069

Stark, 2012, Disease-free probability after the first primary ductal carcinoma in situ of the breast: a comparison between African-American and White-American women, Breast Cancer Res Treat, 131, 561, 10.1007/s10549-011-1742-5

Kerlikowske, 2010, Epidemiology of ductal carcinoma in situ, J Natl Cancer Inst Monogr, 2010, 139, 10.1093/jncimonographs/lgq027

Kerlikowske, 2003, Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy, J Natl Cancer Inst, 95, 1692, 10.1093/jnci/djg097

Warren, 2005, The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis, Cancer, 104, 1840, 10.1002/cncr.21406

Li, 2006, Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988–2001, Cancer, 106, 2104, 10.1002/cncr.21864

Zhou, 2010, Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study, BMC Cancer, 10, 653, 10.1186/1471-2407-10-653

Al-Abbadi, 2006, Differential expression of HER-2/NEU receptor of invasive mammary carcinoma between Caucasian and African American patients in the Detroit metropolitan area, correlation with overall survival and other prognostic factors, Breast Cancer Res Treat, 97, 3, 10.1007/s10549-005-5149-z